Global RNAi for Therapeutic Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Publisher Name :
Date: 14-Feb-2019
No. of pages: 115

RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. RNAi is now known as precise, efficient, stable and better than antisense technology for gene suppression.

Scope of the Report:

RNAi for Therapeutic is in the development stage and there is no use in the market. The fastest research is Clinical phrase III, Such as QP1-1007, QO1-1002 of Quark Pharmaceuticals. The major technology of RNAi for Therapeutic is siRNA, miRNA and shRNA. SiRNA technology is the most popular, with the expenses market share of 85%, following SiRNA, miRNA is the second of 16% expenses market share in 2015.

At present, global expenses concentrates in US and Europe, US takes 80% market share and Europe takes 5% market share. There is A Few R & D Company in the world and the market concentration is high. The top5 (expenses in RNAi for Therapeutic) companies are Alnylam Pharmaceuticals, Arrowhead, Dicerna Pharmaceuticals, Gradalis, miRagen Therapeutics. The five companies occupy about 83% of the market share.

The global RNAi for Therapeutic market is valued at 990 million USD in 2018 and is expected to reach 3580 million USD by the end of 2024, growing at a CAGR of 24.0% between 2019 and 2024.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of RNAi for Therapeutic.

Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.

This report studies the RNAi for Therapeutic market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the RNAi for Therapeutic market by product type and applications/end industries.

Market Segment by Companies, this report covers

- Alnylam Pharmaceuticals

- Arbutus Biopharma (Tekmira)

- Arrowhead

- Dicerna Pharmaceuticals

- Mirna Therapeutics

- Quark Pharmaceuticals

- RXi Pharmaceuticals

- Silence Therapeutics

- Benitec Biopharma

- miRagen Therapeutics

- Sylentis

- Gradalis

- Sirnaomics

- Silenseed

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- siRNA

- miRNA

- shRNA

Market Segment by Applications, can be divided into

- Cancer

- Cardiovascular

- HBV

- Other

Global RNAi for Therapeutic Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 RNAi for Therapeutic Market Overview
1.1 Product Overview and Scope of RNAi for Therapeutic
1.2 Classification of RNAi for Therapeutic by Types
1.2.1 Global RNAi for Therapeutic Revenue Comparison by Types (2019-2024)
1.2.2 Global RNAi for Therapeutic Revenue Market Share by Types in 2018
1.2.3 siRNA
1.2.4 miRNA
1.2.5 shRNA
1.3 Global RNAi for Therapeutic Market by Application
1.3.1 Global RNAi for Therapeutic Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Cancer
1.3.3 Cardiovascular
1.3.4 HBV
1.3.5 Other
1.4 Global RNAi for Therapeutic Market by Regions
1.4.1 Global RNAi for Therapeutic Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) RNAi for Therapeutic Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) RNAi for Therapeutic Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) RNAi for Therapeutic Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) RNAi for Therapeutic Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) RNAi for Therapeutic Status and Prospect (2014-2024)
1.5 Global Market Size of RNAi for Therapeutic (2014-2024)
2 Manufacturers Profiles
2.1 Alnylam Pharmaceuticals
2.1.1 Business Overview
2.1.2 RNAi for Therapeutic Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Alnylam Pharmaceuticals RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
2.2 Arbutus Biopharma (Tekmira)
2.2.1 Business Overview
2.2.2 RNAi for Therapeutic Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Arbutus Biopharma (Tekmira) RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
2.3 Arrowhead
2.3.1 Business Overview
2.3.2 RNAi for Therapeutic Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Arrowhead RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
2.4 Dicerna Pharmaceuticals
2.4.1 Business Overview
2.4.2 RNAi for Therapeutic Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Dicerna Pharmaceuticals RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
2.5 Mirna Therapeutics
2.5.1 Business Overview
2.5.2 RNAi for Therapeutic Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Mirna Therapeutics RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
2.6 Quark Pharmaceuticals
2.6.1 Business Overview
2.6.2 RNAi for Therapeutic Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Quark Pharmaceuticals RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
2.7 RXi Pharmaceuticals
2.7.1 Business Overview
2.7.2 RNAi for Therapeutic Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 RXi Pharmaceuticals RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
2.8 Silence Therapeutics
2.8.1 Business Overview
2.8.2 RNAi for Therapeutic Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Silence Therapeutics RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
2.9 Benitec Biopharma
2.9.1 Business Overview
2.9.2 RNAi for Therapeutic Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Benitec Biopharma RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
2.10 miRagen Therapeutics
2.10.1 Business Overview
2.10.2 RNAi for Therapeutic Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 miRagen Therapeutics RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
2.11 Sylentis
2.11.1 Business Overview
2.11.2 RNAi for Therapeutic Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Sylentis RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
2.12 Gradalis
2.12.1 Business Overview
2.12.2 RNAi for Therapeutic Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Gradalis RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
2.13 Sirnaomics
2.13.1 Business Overview
2.13.2 RNAi for Therapeutic Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Sirnaomics RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
2.14 Silenseed
2.14.1 Business Overview
2.14.2 RNAi for Therapeutic Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Silenseed RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
3 Global RNAi for Therapeutic Market Competition, by Players
3.1 Global RNAi for Therapeutic Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 RNAi for Therapeutic Players Market Share
3.2.2 Top 10 RNAi for Therapeutic Players Market Share
3.3 Market Competition Trend
4 Global RNAi for Therapeutic Market Size by Regions
4.1 Global RNAi for Therapeutic Revenue and Market Share by Regions
4.2 North America RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
4.3 Europe RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
4.5 South America RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
5 North America RNAi for Therapeutic Revenue by Countries
5.1 North America RNAi for Therapeutic Revenue by Countries (2014-2019)
5.2 USA RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
5.3 Canada RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
5.4 Mexico RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
6 Europe RNAi for Therapeutic Revenue by Countries
6.1 Europe RNAi for Therapeutic Revenue by Countries (2014-2019)
6.2 Germany RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
6.3 UK RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
6.4 France RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
6.5 Russia RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
6.6 Italy RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
7 Asia-Pacific RNAi for Therapeutic Revenue by Countries
7.1 Asia-Pacific RNAi for Therapeutic Revenue by Countries (2014-2019)
7.2 China RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
7.3 Japan RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
7.4 Korea RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
7.5 India RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
8 South America RNAi for Therapeutic Revenue by Countries
8.1 South America RNAi for Therapeutic Revenue by Countries (2014-2019)
8.2 Brazil RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
8.3 Argentina RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
8.4 Colombia RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue RNAi for Therapeutic by Countries
9.1 Middle East and Africa RNAi for Therapeutic Revenue by Countries (2014-2019)
9.2 Saudi Arabia RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
9.3 UAE RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
9.4 Egypt RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
9.5 Nigeria RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
9.6 South Africa RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
10 Global RNAi for Therapeutic Market Segment by Type
10.1 Global RNAi for Therapeutic Revenue and Market Share by Type (2014-2019)
10.2 Global RNAi for Therapeutic Market Forecast by Type (2019-2024)
10.3 siRNA Revenue Growth Rate (2014-2024)
10.4 miRNA Revenue Growth Rate (2014-2024)
10.5 shRNA Revenue Growth Rate (2014-2024)
11 Global RNAi for Therapeutic Market Segment by Application
11.1 Global RNAi for Therapeutic Revenue Market Share by Application (2014-2019)
11.2 RNAi for Therapeutic Market Forecast by Application (2019-2024)
11.3 Cancer Revenue Growth (2014-2019)
11.4 Cardiovascular Revenue Growth (2014-2019)
11.5 HBV Revenue Growth (2014-2019)
11.6 Other Revenue Growth (2014-2019)
12 Global RNAi for Therapeutic Market Size Forecast (2019-2024)
12.1 Global RNAi for Therapeutic Market Size Forecast (2019-2024)
12.2 Global RNAi for Therapeutic Market Forecast by Regions (2019-2024)
12.3 North America RNAi for Therapeutic Revenue Market Forecast (2019-2024)
12.4 Europe RNAi for Therapeutic Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific RNAi for Therapeutic Revenue Market Forecast (2019-2024)
12.6 South America RNAi for Therapeutic Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa RNAi for Therapeutic Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure RNAi for Therapeutic Picture
Table Product Specifications of RNAi for Therapeutic
Table Global RNAi for Therapeutic and Revenue (Million USD) Market Split by Product Type
Figure Global RNAi for Therapeutic Revenue Market Share by Types in 2018
Figure siRNA Picture
Figure miRNA Picture
Figure shRNA Picture
Table Global RNAi for Therapeutic Revenue (Million USD) by Application (2014-2024)
Figure RNAi for Therapeutic Revenue Market Share by Applications in 2018
Figure Cancer Picture
Figure Cardiovascular Picture
Figure HBV Picture
Figure Other Picture
Table Global Market RNAi for Therapeutic Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2014-2024)
Table Alnylam Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Alnylam Pharmaceuticals RNAi for Therapeutic Type and Applications
Table Alnylam Pharmaceuticals RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
Table Arbutus Biopharma (Tekmira) Basic Information, Manufacturing Base and Competitors
Table Arbutus Biopharma (Tekmira) RNAi for Therapeutic Type and Applications
Table Arbutus Biopharma (Tekmira) RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
Table Arrowhead Basic Information, Manufacturing Base and Competitors
Table Arrowhead RNAi for Therapeutic Type and Applications
Table Arrowhead RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
Table Dicerna Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Dicerna Pharmaceuticals RNAi for Therapeutic Type and Applications
Table Dicerna Pharmaceuticals RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
Table Mirna Therapeutics Basic Information, Manufacturing Base and Competitors
Table Mirna Therapeutics RNAi for Therapeutic Type and Applications
Table Mirna Therapeutics RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
Table Quark Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Quark Pharmaceuticals RNAi for Therapeutic Type and Applications
Table Quark Pharmaceuticals RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
Table RXi Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table RXi Pharmaceuticals RNAi for Therapeutic Type and Applications
Table RXi Pharmaceuticals RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
Table Silence Therapeutics Basic Information, Manufacturing Base and Competitors
Table Silence Therapeutics RNAi for Therapeutic Type and Applications
Table Silence Therapeutics RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
Table Benitec Biopharma Basic Information, Manufacturing Base and Competitors
Table Benitec Biopharma RNAi for Therapeutic Type and Applications
Table Benitec Biopharma RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
Table miRagen Therapeutics Basic Information, Manufacturing Base and Competitors
Table miRagen Therapeutics RNAi for Therapeutic Type and Applications
Table miRagen Therapeutics RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
Table Sylentis Basic Information, Manufacturing Base and Competitors
Table Sylentis RNAi for Therapeutic Type and Applications
Table Sylentis RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
Table Gradalis Basic Information, Manufacturing Base and Competitors
Table Gradalis RNAi for Therapeutic Type and Applications
Table Gradalis RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
Table Sirnaomics Basic Information, Manufacturing Base and Competitors
Table Sirnaomics RNAi for Therapeutic Type and Applications
Table Sirnaomics RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
Table Silenseed Basic Information, Manufacturing Base and Competitors
Table Silenseed RNAi for Therapeutic Type and Applications
Table Silenseed RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
Table Global RNAi for Therapeutic Revenue (Million USD) by Players (2014-2019)
Table Global RNAi for Therapeutic Revenue Share by Players (2014-2019)
Figure Global RNAi for Therapeutic Revenue Share by Players in 2017
Figure Global RNAi for Therapeutic Revenue Share by Players in 2018
Figure Global Top 5 Players RNAi for Therapeutic Revenue Market Share in 2018
Figure Global Top 10 Players RNAi for Therapeutic Revenue Market Share in 2018
Figure Global RNAi for Therapeutic Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global RNAi for Therapeutic Revenue (Million USD) by Regions (2014-2019)
Table Global RNAi for Therapeutic Revenue Market Share by Regions (2014-2019)
Figure Global RNAi for Therapeutic Revenue Market Share by Regions (2014-2019)
Figure Global RNAi for Therapeutic Revenue Market Share by Regions in 2018
Figure North America RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
Figure Europe RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
Figure South America RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
Table North America RNAi for Therapeutic Revenue by Countries (2014-2019)
Table North America RNAi for Therapeutic Revenue Market Share by Countries (2014-2019)
Figure North America RNAi for Therapeutic Revenue Market Share by Countries (2014-2019)
Figure North America RNAi for Therapeutic Revenue Market Share by Countries in 2018
Figure USA RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
Figure Canada RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
Figure Mexico RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
Table Europe RNAi for Therapeutic Revenue (Million USD) by Countries (2014-2019)
Figure Europe RNAi for Therapeutic Revenue Market Share by Countries (2014-2019)
Figure Europe RNAi for Therapeutic Revenue Market Share by Countries in 2018
Figure Germany RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
Figure UK RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
Figure France RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
Figure Russia RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
Figure Italy RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
Table Asia-Pacific RNAi for Therapeutic Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific RNAi for Therapeutic Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific RNAi for Therapeutic Revenue Market Share by Countries in 2018
Figure China RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
Figure Japan RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
Figure Korea RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
Figure India RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
Figure Southeast Asia RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
Table South America RNAi for Therapeutic Revenue by Countries (2014-2019)
Table South America RNAi for Therapeutic Revenue Market Share by Countries (2014-2019)
Figure South America RNAi for Therapeutic Revenue Market Share by Countries (2014-2019)
Figure South America RNAi for Therapeutic Revenue Market Share by Countries in 2018
Figure Brazil RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
Figure Argentina RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
Figure Colombia RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
Table Middle East and Africa RNAi for Therapeutic Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa RNAi for Therapeutic Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa RNAi for Therapeutic Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa RNAi for Therapeutic Revenue Market Share by Countries in 2018
Figure Saudi Arabia RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
Figure UAE RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
Figure Egypt RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
Figure Nigeria RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
Figure South Africa RNAi for Therapeutic Revenue and Growth Rate (2014-2019)
Table Global RNAi for Therapeutic Revenue (Million USD) by Type (2014-2019)
Table Global RNAi for Therapeutic Revenue Share by Type (2014-2019)
Figure Global RNAi for Therapeutic Revenue Share by Type (2014-2019)
Figure Global RNAi for Therapeutic Revenue Share by Type in 2019
Table Global RNAi for Therapeutic Revenue Forecast by Type (2019-2024)
Figure Global RNAi for Therapeutic Market Share Forecast by Type (2019-2024)
Figure Global siRNA Revenue Growth Rate (2014-2019)
Figure Global miRNA Revenue Growth Rate (2014-2019)
Figure Global shRNA Revenue Growth Rate (2014-2019)
Table Global RNAi for Therapeutic Revenue by Application (2014-2019)
Table Global RNAi for Therapeutic Revenue Share by Application (2014-2019)
Figure Global RNAi for Therapeutic Revenue Share by Application (2014-2019)
Figure Global RNAi for Therapeutic Revenue Share by Application in 2019
Table Global RNAi for Therapeutic Revenue Forecast by Application (2019-2024)
Figure Global RNAi for Therapeutic Market Share Forecast by Application (2019-2024)
Figure Global Cancer Revenue Growth Rate (2014-2019)
Figure Global Cardiovascular Revenue Growth Rate (2014-2019)
Figure Global HBV Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Figure Global RNAi for Therapeutic Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global RNAi for Therapeutic Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global RNAi for Therapeutic Revenue Market Share Forecast by Regions (2019-2024)
Figure North America RNAi for Therapeutic Revenue Market Forecast (2019-2024)
Figure Europe RNAi for Therapeutic Revenue Market Forecast (2019-2024)
Figure Asia-Pacific RNAi for Therapeutic Revenue Market Forecast (2019-2024)
Figure South America RNAi for Therapeutic Revenue Market Forecast (2019-2024)
Figure Middle East and Africa RNAi for Therapeutic Revenue Market Forecast (2019-2024)
  • Global RNAi for Therapeutic Market Research Report 2015-2025
    Published: 25-Feb-2020        Price: US 1800 Onwards        Pages: 82
    Summary RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. RNAi is now known as precise, efficient, stable and be......
  • Global Antisense and RNAi Therapeutics Market 2020 by Company, Regions, Type and Application, Forecast to 2025
    Published: 24-Feb-2020        Price: US 3480 Onwards        Pages: 103
    Market Overview The global Antisense and RNAi Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Antisense and RNAi Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive......
  • Global Targeted RNA Sequencing Market Analysis 2015-2019 and Forecast 2020-2025
    Published: 23-Feb-2020        Price: US 2980 Onwards        Pages: 84
    Snapshot The global Targeted RNA Sequencing market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Targeted RNA Sequencing by product, region and application, in addition, this report introduces market competition situation among the vendors ......
  • Global RNAi for Therapeutic Market Data Survey Report 2015-2025
    Published: 11-Feb-2020        Price: US 1500 Onwards        Pages: 61
    Summary RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. RNAi is now known as precise, efficient, stable and be......
  • RNAi Therapeutics Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 09-Feb-2020        Price: US 3000 Onwards        Pages: 147
    RNAi Therapeutics Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global RNAi Therapeutics industry with a focus on the Chinese market. The report provides key statistics on the market status of the RNAi Therapeutics manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-2024 global and Chinese RNAi Therape......
  • RNAi for Therapeutic Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 09-Feb-2020        Price: US 3000 Onwards        Pages: 148
    RNAi for Therapeutic Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global RNAi for Therapeutic industry with a focus on the Chinese market. The report provides key statistics on the market status of the RNAi for Therapeutic manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-2024 global and Chinese RNA......
  • Antisense and RNAI Therapeutics Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 06-Feb-2020        Price: US 3000 Onwards        Pages: 143
    Antisense and RNAi Therapeutics Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Antisense and RNAi Therapeutics industry with a focus on the Chinese market. The report provides key statistics on the market status of the Antisense and RNAi Therapeutics manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Overall, the report provides an in-depth insight of ......
  • 2020-2025 Global and Regional RNAi for Therapeutic Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report
    Published: 05-Feb-2020        Price: US 3500 Onwards        Pages: 165
    HNY Research projects that the RNAi for Therapeutic market size will grow from XXX in 2019 to XXX by 2025, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2025. By Market Players: Alnylam Pharmaceuticals, Silence Therapeutics, Dicerna Pharmaceuticals, Arbutus Biopharma (Tekmira), RXi Pharmaceuticals, Arrowhead, miRagen Therapeutics, Quark Pharmaceuticals, Mirna Therapeutics, Benitec Biopharma, Sylenti......
  • Global RNAi for Therapeutic Market Growth (Status and Outlook) 2020-2025
    Published: 21-Jan-2020        Price: US 3660 Onwards        Pages: 137
    According to this study, over the next five years the RNAi for Therapeutic market will register a 24.0% CAGR in terms of revenue, the global market size will reach $ 3515.2 million by 2025, from $ 1488.6 million in 2019. In particular, this report presents the global revenue market share of key companies in RNAi for Therapeutic business, shared in Chapter 3. This report presents a comprehensive overview, market shares and growth opportunities of RNAi for Therapeutic market by type......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs